Norinchukin Bank’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.67M Buy
9,420
+1,355
+17% +$573K 0.04% 243
2026
Q1
$3.82M Sell
8,065
-165
-2% -$83.1K 0.04% 222
2025
Q4
$3.84M Sell
8,230
-7
-0.1% -$3.25K 0.04% 214
2025
Q3
$3.51M Sell
8,237
-81
-1% -$31.4K 0.05% 217
2025
Q2
$3.19M Buy
8,318
+352
+4% +$127K 0.05% 216
2025
Q1
$2.75M Buy
7,966
+770
+11% +$248K 0.05% 219
2024
Q4
$2.16M Buy
7,196
+74
+1% +$25.9K 0.05% 228
2024
Q3
$2.89M Buy
7,122
+491
+7% +$180K 0.07% 173
2024
Q2
$2.13M Sell
6,631
-41
-0.6% -$13.3K 0.06% 182
2024
Q1
$2.23M Sell
6,672
-88
-1% -$26.9K 0.07% 179
2023
Q4
$1.83M Sell
6,760
-455
-6% -$112K 0.04% 191
2023
Q3
$1.77M Sell
7,215
-4,832
-40% -$1.32M 0.04% 207
2023
Q2
$3.66M Buy
12,047
+425
+4% +$118K 0.06% 198
2023
Q1
$3.06M Buy
11,622
+416
+4% +$106K 0.06% 186
2022
Q4
$2.69M Sell
11,206
-1,531
-12% -$343K 0.06% 196
2022
Q3
$2.34M Buy
12,737
+202
+2% +$40.2K 0.05% 238
2022
Q2
$2.11M Sell
12,535
-9,066
-42% -$1.95M 0.04% 239
2022
Q1
$5.41M Buy
21,601
+1,262
+6% +$317K 0.07% 157
2021
Q4
$5.22M Sell
20,339
-718
-3% -$176K 0.07% 155
2021
Q3
$5.11M Sell
21,057
-690
-3% -$169K 0.07% 146
2021
Q2
$4.5M Sell
21,747
-307
-1% -$62.6K 0.07% 155
2021
Q1
$4.15M Buy
22,054
+453
+2% +$79.9K 0.06% 151
2020
Q4
$3.55M Sell
21,601
-513
-2% -$75K 0.05% 158
2020
Q3
$2.76M Buy
22,114
+289
+1% +$35.8K 0.04% 174
2020
Q2
$2.12M Sell
21,825
-314
-1% -$32.6K 0.04% 204
2020
Q1
$1.99M Sell
22,139
-12,896
-37% -$1.67M 0.04% 182
2019
Q4
$5.18M Sell
35,035
-3,485
-9% -$468K 0.07% 164
2019
Q3
$4.64M Buy
38,520
+879
+2% +$114K 0.07% 178
2019
Q2
$5.09M Sell
37,641
-13,019
-26% -$1.65M 0.08% 160
2019
Q1
$6.61M Buy
50,660
+1,483
+3% +$199K 0.08% 156
2018
Q4
$6.12M Buy
49,177
+14,461
+42% +$1.94M 0.09% 148
2018
Q3
$4.83M Buy
34,716
+3,056
+10% +$380K 0.07% 154
2018
Q2
$3.25M Buy
31,660
+6,010
+23% +$608K 0.05% 187
2018
Q1
$2.49M Sell
25,650
-5,125
-17% -$497K 0.04% 205
2017
Q4
$2.7M Sell
30,775
-11,440
-27% -$919K 0.05% 186
2017
Q3
$3.36M Buy
42,215
+3,462
+9% +$278K 0.07% 166
2017
Q2
$3.38M Sell
38,753
-883
-2% -$74.7K 0.07% 155
2017
Q1
$3.53M Buy
39,636
+3,310
+9% +$276K 0.08% 137
2016
Q4
$2.69M Buy
36,326
+2,043
+6% +$153K 0.06% 152
2016
Q3
$2.59M Sell
34,283
-19,138
-36% -$1.47M 0.06% 152
2016
Q2
$4.11M Sell
53,421
-6,122
-10% -$483K 0.1% 126
2016
Q1
$4.65M Buy
59,543
+7,635
+15% +$533K 0.11% 119
2015
Q4
$3.51M Buy
51,908
+4,254
+9% +$297K 0.09% 131
2015
Q3
$3.69M Buy
47,654
+11,149
+31% +$987K 0.1% 125
2015
Q2
$3.31M Buy
36,505
+19,050
+109% +$1.53M 0.08% 123
2015
Q1
$1.31M Buy
+17,455
New +$1.25M 0.03% 290

Other funds holding HCA

Norinchukin Bank's HCA Position: Q2 2026 in Review

Norinchukin Bank increased its HCA Healthcare (HCA) stake by 17% in Q2 2026, buying an estimated $573K and bringing the position to 9,420 shares worth $3.67M. The position accounts for 0.04% of the portfolio, ranked #243.

Norinchukin Bank first reported a position in HCA in Q1 2015 and has held it in 46 quarters since. The position peaked at $6.61M in Q1 2019. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Norinchukin Bank held 9,420 shares of HCA Healthcare worth $3.67M as of Q2 2026.
  • Norinchukin Bank bought 1,355 HCA Healthcare shares in Q2 2026, an estimated $573K.
  • HCA Healthcare made up 0.04% of Norinchukin Bank's portfolio in Q2 2026, its #243 holding.
  • Norinchukin Bank first reported a position in HCA Healthcare in Q1 2015 and has held it in 46 quarters since.
  • Norinchukin Bank's HCA Healthcare position peaked at $6.61M in Q1 2019.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Norinchukin Bank's 13F filing for Q2 2026, filed 14 Aug 2026.